Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

267 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.
Cabezón T, Gromova I, Gromov P, Serizawa R, Timmermans Wielenga V, Kroman N, Celis JE, Moreira JM. Cabezón T, et al. Among authors: celis je. Mol Cell Proteomics. 2013 Feb;12(2):381-94. doi: 10.1074/mcp.M112.019786. Epub 2012 Nov 20. Mol Cell Proteomics. 2013. PMID: 23172894 Free PMC article.
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research.
Celis JE, Gromov P, Gromova I, Moreira JM, Cabezón T, Ambartsumian N, Grigorian M, Lukanidin E, Thor Straten P, Guldberg P, Bartkova J, Bartek J, Lukas J, Lukas C, Lykkesfeldt A, Jäättelä M, Roepstorff P, Bolund L, Ørntoft T, Brünner N, Overgaard J, Sandelin K, Blichert-Toft M, Mouridsen H, Rank FE. Celis JE, et al. Mol Cell Proteomics. 2003 Jun;2(6):369-77. doi: 10.1074/mcp.R300007-MCP200. Epub 2003 Jun 25. Mol Cell Proteomics. 2003. PMID: 12832461
267 results